Verve Therapeutics (VERV) Presents at the TIDES USA Annual Event - Slideshow

1 | --- | --- | --- | --- | |-------|-------|------------------------|-------------------------------------------------| | | | | | | | | | | | | | to Treat ASCVD | Verve Therapeutics: In Vivo CRISPR Base Editing | | | | TIDES USA Annual Event | Andrew Bellinger, MD PhD | | | | May 11, 2022 | | Disclosure I am an employee of Verve Therapeutics. This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and ...